Young women across certain regions of England are facing an elevated risk of cervical cancer, a direct consequence of alarmingly low uptake rates for the preventative human papillomavirus (HPV) vaccine, health experts have cautioned.
Analysis from the UK Health Security Agency (UKHSA) underscores this critical public health concern, revealing that insufficient vaccination among children is leaving many women vulnerable to the disease.
